Published in J Virol on October 01, 1994
The T-cell-independent role of gamma interferon and tumor necrosis factor alpha in macrophage activation during murine cytomegalovirus and herpes simplex virus infections. J Virol (1995) 2.45
Major histocompatibility complex class I allele-specific cooperative and competitive interactions between immune evasion proteins of cytomegalovirus. J Exp Med (2002) 2.37
Disruption of the murine gammaherpesvirus 68 M1 open reading frame leads to enhanced reactivation from latency. J Virol (2000) 2.33
Identification and characterization of a G protein-coupled receptor homolog encoded by murine cytomegalovirus. J Virol (1997) 1.79
Human cytomegalovirus induces monocyte differentiation and migration as a strategy for dissemination and persistence. J Virol (2004) 1.66
The impact of regulatory T cells on T-cell immunity following hematopoietic cell transplantation. Blood (2007) 1.57
Characterization of human cytomegalovirus glycoprotein-induced cell-cell fusion. J Virol (2005) 1.56
Cytomegalovirus-encoded beta chemokine promotes monocyte-associated viremia in the host. Proc Natl Acad Sci U S A (1999) 1.53
Shedding light on the elusive role of endothelial cells in cytomegalovirus dissemination. PLoS Pathog (2011) 1.51
Pathogenesis of experimental rhesus cytomegalovirus infection. J Virol (1999) 1.50
The ribonucleotide reductase R1 homolog of murine cytomegalovirus is not a functional enzyme subunit but is required for pathogenesis. J Virol (2004) 1.50
Frequent coinfection of cells explains functional in vivo complementation between cytomegalovirus variants in the multiply infected host. J Virol (2005) 1.46
Susceptibility of immature and mature Langerhans cell-type dendritic cells to infection and immunomodulation by human cytomegalovirus. J Virol (2003) 1.44
Human cytomegalovirus (HCMV) infection of endothelial cells promotes naive monocyte extravasation and transfer of productive virus to enhance hematogenous dissemination of HCMV. J Virol (2006) 1.44
Virus attenuation after deletion of the cytomegalovirus Fc receptor gene is not due to antibody control. J Virol (1998) 1.44
Murine cytomegalovirus with a deletion of genes spanning HindIII-J and -I displays altered cell and tissue tropism. J Virol (1996) 1.43
Replication of murine cytomegalovirus in differentiated macrophages as a determinant of viral pathogenesis. J Virol (1999) 1.42
Murine cytomegalovirus displays selective infection of cells within hours after systemic administration. J Gen Virol (2009) 1.40
Pathogenesis of herpes simplex virus type 2 virion host shutoff (vhs) mutants. J Virol (2002) 1.39
Mitochondrial cell death suppressors carried by human and murine cytomegalovirus confer resistance to proteasome inhibitor-induced apoptosis. J Virol (2005) 1.39
Late expression of a beta chemokine homolog by murine cytomegalovirus. J Virol (1997) 1.39
Murine cytomegalovirus CC chemokine homolog MCK-2 (m131-129) is a determinant of dissemination that increases inflammation at initial sites of infection. J Virol (2001) 1.37
The R33 G protein-coupled receptor gene of rat cytomegalovirus plays an essential role in the pathogenesis of viral infection. J Virol (1998) 1.36
Structure and function of the murine cytomegalovirus sgg1 gene: a determinant of viral growth in salivary gland acinar cells. J Virol (1994) 1.32
The murine cytomegalovirus chemokine homolog, m131/129, is a determinant of viral pathogenicity. J Virol (1999) 1.32
Novel cell type-specific antiviral mechanism of interferon gamma action in macrophages. J Exp Med (2001) 1.28
Processing and presentation of murine cytomegalovirus pORFm164-derived peptide in fibroblasts in the face of all viral immunosubversive early gene functions. J Virol (2002) 1.19
Roles of phosphatidylinositol 3-kinase and NF-kappaB in human cytomegalovirus-mediated monocyte diapedesis and adhesion: strategy for viral persistence. J Virol (2007) 1.18
The salivary glands as a privileged site of cytomegalovirus immune evasion and persistence. Med Microbiol Immunol (2008) 1.17
Cytomegalovirus MCK-2 controls mobilization and recruitment of myeloid progenitor cells to facilitate dissemination. Blood (2005) 1.15
Use of a murine cytomegalovirus K181-derived bacterial artificial chromosome as a vaccine vector for immunocontraception. J Virol (2005) 1.15
Sequences within the herpesvirus-conserved pac1 and pac2 motifs are required for cleavage and packaging of the murine cytomegalovirus genome. J Virol (1998) 1.15
The ends on herpesvirus DNA replicative concatemers contain pac2 cis cleavage/packaging elements and their formation is controlled by terminal cis sequences. J Virol (2000) 1.11
Direct interactions of coxsackievirus B3 with immune cells in the splenic compartment of mice susceptible or resistant to myocarditis. J Virol (1996) 1.11
Identification of a mouse cytomegalovirus gene selectively targeting CD86 expression on antigen-presenting cells. J Virol (2004) 1.11
Macrophages escape inhibition of major histocompatibility complex class I-dependent antigen presentation by cytomegalovirus. J Virol (2000) 1.10
Cytomegalovirus impairs antiviral CD8+ T cell immunity by recruiting inflammatory monocytes. Immunity (2012) 1.07
Protein pUL128 of human cytomegalovirus is necessary for monocyte infection and blocking of migration. J Virol (2011) 1.07
Dysregulated interferon-gamma responses during lethal cytomegalovirus brain infection of IL-10-deficient mice. Virus Res (2007) 1.00
Passive immunization reduces murine cytomegalovirus-induced brain pathology in newborn mice. J Virol (2008) 0.99
Murine cytomegalovirus paralyzes macrophages by blocking IFN gamma-induced promoter assembly. Proc Natl Acad Sci U S A (2003) 0.98
Murine cytomegalovirus infection inhibits tumor necrosis factor alpha responses in primary macrophages. J Virol (2003) 0.97
A spread-deficient cytomegalovirus for assessment of first-target cells in vaccination. J Virol (2010) 0.96
The M33 chemokine receptor homolog of murine cytomegalovirus exhibits a differential tissue-specific role during in vivo replication and latency. J Virol (2009) 0.95
Memory T cells persisting in the brain following MCMV infection induce long-term microglial activation via interferon-γ. J Neurovirol (2011) 0.95
Dissemination of rat cytomegalovirus through infected granulocytes and monocytes in vitro and in vivo. J Virol (2003) 0.94
Cytomegalovirus hijacks CX3CR1(hi) patrolling monocytes as immune-privileged vehicles for dissemination in mice. Cell Host Microbe (2014) 0.94
Murine cytomegalovirus abortively infects human dendritic cells, leading to expression and presentation of virally vectored genes. J Virol (2003) 0.92
Differential expression of the immediate-early and early antigens in neuronal and glial cells of developing mouse brains infected with murine cytomegalovirus. Am J Pathol (1997) 0.91
Amphipathic DNA polymers exhibit antiviral activity against systemic murine Cytomegalovirus infection. Virol J (2009) 0.91
Absence of vasoactive intestinal peptide expression in hematopoietic cells enhances Th1 polarization and antiviral immunity in mice. J Immunol (2011) 0.91
Neutrophils recruited by IL-22 in peripheral tissues function as TRAIL-dependent antiviral effectors against MCMV. Cell Host Microbe (2014) 0.90
Reactivation of latent cytomegalovirus infection in mouse brain cells detected after transfer to brain slice cultures. J Virol (2002) 0.89
Partial functional complementation between human and mouse cytomegalovirus chemokine receptor homologues. J Virol (2011) 0.89
Lymph Node Macrophages Restrict Murine Cytomegalovirus Dissemination. J Virol (2015) 0.89
Mast cells as rapid innate sensors of cytomegalovirus by TLR3/TRIF signaling-dependent and -independent mechanisms. Cell Mol Immunol (2014) 0.88
Machinery to support genome segment inversion exists in a herpesvirus which does not naturally contain invertible elements. J Virol (2000) 0.87
Cytomegalovirus-induced sensorineural hearing loss with persistent cochlear inflammation in neonatal mice. J Neurovirol (2011) 0.86
Persistent humoral immune responses in the CNS limit recovery of reactivated murine cytomegalovirus. PLoS One (2012) 0.86
Cytomegalovirus infection and interferon-gamma modulate major histocompatibility complex class I expression on neural stem cells. J Neurovirol (2008) 0.85
HCMV reprogramming of infected monocyte survival and differentiation: a Goldilocks phenomenon. Viruses (2014) 0.85
Type 1 Interferons and NK Cells Limit Murine Cytomegalovirus Escape from the Lymph Node Subcapsular Sinus. PLoS Pathog (2016) 0.84
Ligand induction of retinoic acid receptors alters an acute infection by murine cytomegalovirus. J Virol (1998) 0.84
Excess neutrophil infiltration during cytomegalovirus brain infection of interleukin-10-deficient mice. J Neuroimmunol (2010) 0.83
Infiltrating regulatory B cells control neuroinflammation following viral brain infection. J Immunol (2014) 0.83
Reduced lymphocyte infiltration during cytomegalovirus brain infection of interleukin-10-deficient mice. J Neurovirol (2009) 0.83
Mck2-dependent infection of alveolar macrophages promotes replication of MCMV in nodular inflammatory foci of the neonatal lung. Mucosal Immunol (2014) 0.83
Antiviral T cell response triggers cytomegalovirus hepatitis in mice. J Virol (2012) 0.82
Glial cells suppress postencephalitic CD8+ T lymphocytes through PD-L1. Glia (2014) 0.82
MCMV-mediated inhibition of the pro-apoptotic Bak protein is required for optimal in vivo replication. PLoS Pathog (2013) 0.81
Cytomegalovirus m154 hinders CD48 cell-surface expression and promotes viral escape from host natural killer cell control. PLoS Pathog (2014) 0.81
Peptide inhibition of human cytomegalovirus infection. Virol J (2011) 0.81
Murine cytomegalovirus infection of mouse macrophages stimulates early expression of suppressor of cytokine signaling (SOCS)1 and SOCS3. PLoS One (2017) 0.80
CMV infection attenuates the disease course in a murine model of multiple sclerosis. PLoS One (2012) 0.79
Ablation of the regulatory IE1 protein of murine cytomegalovirus alters in vivo pro-inflammatory TNF-alpha production during acute infection. PLoS Pathog (2012) 0.79
Chronic reactive gliosis following regulatory T cell depletion during acute MCMV encephalitis. Glia (2015) 0.79
CD200 receptor restriction of myeloid cell responses antagonizes antiviral immunity and facilitates cytomegalovirus persistence within mucosal tissue. PLoS Pathog (2015) 0.79
Cytomegalovirus immune evasion of myeloid lineage cells. Med Microbiol Immunol (2015) 0.78
The PD-1: PD-L1 pathway promotes development of brain-resident memory T cells following acute viral encephalitis. J Neuroinflammation (2017) 0.78
Co-transplantation of pure blood stem cells with antigen-specific but not bulk T cells augments functional immunity. Proc Natl Acad Sci U S A (2012) 0.78
Tumor control in a model of bone marrow transplantation and acute liver-infiltrating B-cell lymphoma: an unpredicted novel function of cytomegalovirus. J Virol (2002) 0.77
Gene products of the embedded m41/m41.1 locus of murine cytomegalovirus differentially influence replication and pathogenesis. Virology (2013) 0.77
Tregs Modulate Lymphocyte Proliferation, Activation, and Resident-Memory T-Cell Accumulation within the Brain during MCMV Infection. PLoS One (2015) 0.77
Herpes Simplex Virus 1 Interaction with Myeloid Cells In Vivo. J Virol (2016) 0.77
Vascular dysfunction in young, mid-aged and aged mice with latent cytomegalovirus infections. Am J Physiol Heart Circ Physiol (2012) 0.76
Glial cell activation, recruitment, and survival of B-lineage cells following MCMV brain infection. J Neuroinflammation (2016) 0.76
The Cytoplasmic C-Tail of the Mouse Cytomegalovirus 7 Transmembrane Receptor Homologue, M78, Regulates Endocytosis of the Receptor and Modulates Virus Replication in Different Cell Types. PLoS One (2016) 0.75
Heterologous immunity and persistent murine cytomegalovirus infection. J Virol (2016) 0.75
Modulation of Microglial Cell Fcγ Receptor Expression Following Viral Brain Infection. Sci Rep (2017) 0.75
Tissue-specific control of latent CMV reactivation by regulatory T cells. PLoS Pathog (2017) 0.75
Murine Cytomegalovirus Spreads by Dendritic Cell Recirculation. MBio (2017) 0.75
Intratumoral infection by CMV may change the tumor environment by directly interacting with tumor-associated macrophages to promote cancer immunity. Hum Vaccin Immunother (2017) 0.75
"A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity". Addendum. Anal Biochem (1984) 66.58
The dendritic cell system and its role in immunogenicity. Annu Rev Immunol (1991) 23.09
Identification of proliferating dendritic cell precursors in mouse blood. J Exp Med (1992) 5.03
Interstitial murine cytomegalovirus pneumonia after irradiation: characterization of cells that limit viral replication during established infection of the lungs. J Virol (1985) 4.76
Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J Gen Virol (1991) 4.61
CD8-positive T lymphocytes specific for murine cytomegalovirus immediate-early antigens mediate protective immunity. J Virol (1987) 4.58
Cytomegalovirus infects human lymphocytes and monocytes: virus expression is restricted to immediate-early gene products. Proc Natl Acad Sci U S A (1984) 4.56
Regulation of cytomegalovirus gene expression: alpha and beta promoters are trans activated by viral functions in permissive human fibroblasts. J Virol (1985) 4.39
Human cytomegalovirus ie1 transactivates the alpha promoter-enhancer via an 18-base-pair repeat element. J Virol (1989) 4.25
Widespread presence of histologically occult cytomegalovirus. Hum Pathol (1984) 3.45
Dendritic cell progenitors phagocytose particulates, including bacillus Calmette-Guerin organisms, and sensitize mice to mycobacterial antigens in vivo. J Exp Med (1993) 3.39
Cells in the marginal zone of the spleen. Int Rev Cytol (1992) 3.27
Granulocytes, macrophages, and dendritic cells arise from a common major histocompatibility complex class II-negative progenitor in mouse bone marrow. Proc Natl Acad Sci U S A (1993) 3.25
A cis-acting element within the 5' leader of a cytomegalovirus beta transcript determines kinetic class. Cell (1986) 3.20
Human cytomegalovirus productively infects primary differentiated macrophages. J Virol (1991) 3.16
Insertion and deletion mutagenesis of the human cytomegalovirus genome. Proc Natl Acad Sci U S A (1987) 3.04
Site-restricted persistent cytomegalovirus infection after selective long-term depletion of CD4+ T lymphocytes. J Exp Med (1989) 2.89
Sequence and structural organization of murine cytomegalovirus immediate-early gene 1. J Virol (1987) 2.84
Regulation of cytomegalovirus late gene expression: gamma genes are controlled by posttranscriptional events. J Virol (1986) 2.84
Gamma interferon-dependent clearance of cytomegalovirus infection in salivary glands. J Virol (1992) 2.67
Temporal regulation of murine cytomegalovirus transcription and mapping of viral RNA synthesized at immediate early times after infection. J Virol (1984) 2.62
Immediate-early genes of murine cytomegalovirus: location, transcripts, and translation products. J Virol (1987) 2.30
Insertional mutagenesis of the murine cytomegalovirus genome: one prominent alpha gene (ie2) is dispensable for growth. Virology (1988) 2.17
Structural organization, expression, and functional characterization of the murine cytomegalovirus immediate-early gene 3. J Virol (1992) 2.08
Localization of human cytomegalovirus in peripheral blood leukocytes by in situ hybridization. J Infect Dis (1990) 2.08
Unrestricted replication of human cytomegalovirus in hydrocortisone-treated macrophages. J Virol (1991) 2.07
Molecular cloning and restriction endonuclease mapping of the murine cytomegalovirus genome (Smith Strain). Virology (1983) 2.06
Disseminated cytomegalovirus infection. Molecular analysis of virus and leukocyte interactions in viremia. J Clin Invest (1988) 2.05
Herpes simplex virus latent RNA (LAT) is not required for latent infection in the mouse. Proc Natl Acad Sci U S A (1989) 2.05
Pathogenesis of murine cytomegalovirus infection: the macrophage as a permissive cell for cytomegalovirus infection, replication and latency. J Gen Virol (1979) 2.01
Cellular and molecular basis of the protective immune response to cytomegalovirus infection. Curr Top Microbiol Immunol (1990) 2.00
Genes in the HindIII J fragment of the murine cytomegalovirus genome are dispensable for growth in cultured cells: insertion mutagenesis with a lacZ/gpt cassette. J Virol (1994) 1.98
Pathogenesis of murine cytomegalovirus infection: identification of infected cells in the spleen during acute and latent infections. J Virol (1988) 1.83
Regulation of cytomegalovirus late-gene expression: differential use of three start sites in the transcriptional activation of ICP36 gene expression. J Virol (1989) 1.83
Cytomegalovirus determinant of replication in salivary glands. J Virol (1992) 1.82
The role of macrophages in mice infected with murine cytomegalovirus. J Gen Virol (1978) 1.71
Human cytomegalovirus in a SCID-hu mouse: thymic epithelial cells are prominent targets of viral replication. Proc Natl Acad Sci U S A (1993) 1.70
Circulating cytomegalovirus (CMV)-infected endothelial cells in patients with an active CMV infection. J Infect Dis (1993) 1.62
Beta-galactosidase as a marker in the peripheral and neural tissues of the herpes simplex virus-infected mouse. Virology (1988) 1.60
Infection of adult mouse macrophages in vitro with cytomegalovirus. Proc Soc Exp Biol Med (1968) 1.53
Late-phase expression of a murine cytomegalovirus immediate-early antigen recognized by cytolytic T lymphocytes. J Virol (1986) 1.48
Cytomegalovirus infections associated with leukocyte transfusions. Ann Intern Med (1980) 1.44
Modification by adoptive humoral immunity of murine cytomegalovirus infection. J Infect Dis (1981) 1.43
Interactions of human cytomegalovirus with leukocytes in vivo: analysis by in situ hybridization. Microb Pathog (1987) 1.39
Structure and expression of murine cytomegalovirus immediate-early gene 2. J Virol (1991) 1.37
Spontaneous activation of latent cytomegalovirus from murine spleen explants. Role of lymphocytes and macrophages in release and replication of virus. J Clin Invest (1982) 1.30
Polymorphonuclear cells are not sites of persistence of human cytomegalovirus in healthy individuals. J Gen Virol (1993) 1.26
Splenic necrosis in mice infected with cytomegalovirus. J Infect Dis (1978) 1.25
Transmission and activation of cytomegalovirus with blood transfusion: a mouse model. J Infect Dis (1977) 1.24
Infection of mononucleated phagocytes with human cytomegalovirus. Virology (1993) 1.23
Latent infections induced by herpes simplex viruses. Cancer Res (1973) 1.20
Interaction of strain AD169 and a clinical isolate of cytomegalovirus with peripheral monocytes: the effect of lipopolysaccharide stimulation. J Infect Dis (1987) 1.17
Detection of murine cytomegalovirus DNA in circulating leukocytes harvested during acute infection of mice. J Virol (1989) 1.14
Acute murine cytomegalovirus infection induces lethal hepatitis. J Infect Dis (1993) 1.13
Detection of mouse cytomegalovirus nucleic acid in latently infected mice by in vitro enzymatic amplification. J Infect Dis (1990) 1.11
The relation of viral replication to interstitial pneumonitis in murine cytomegalovirus lung infection. J Infect Dis (1985) 1.10
Infection of salivary glands, kidneys, adrenals, ovaries and epithelia by murine cytomegalovirus. J Med Microbiol (1979) 1.09
Isolation and identification of feline peritoneal macrophages for in vitro studies of coronavirus-macrophage interactions. J Leukoc Biol (1988) 0.96
Cytomegalovirus-specific lymphocyte transformations in subjects of different ages with primary immunodeficiency. Infect Immun (1980) 0.93
Effect of cyclosporine on the response of normal human lymphocytes to cytomegalovirus in vitro. Infect Immun (1983) 0.87
Cloning of reiterated and nonreiterated herpes simplex virus 1 sequences as BamHI fragments. Proc Natl Acad Sci U S A (1980) 6.66
Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. J Virol (1996) 6.64
Molecular engineering of the herpes simplex virus genome: insertion of a second L-S junction into the genome causes additional genome inversions. Cell (1980) 4.47
Regulation of cytomegalovirus gene expression: alpha and beta promoters are trans activated by viral functions in permissive human fibroblasts. J Virol (1985) 4.39
Structure and role of the herpes simplex virus DNA termini in inversion, circularization and generation of virion DNA. Cell (1982) 4.36
Human cytomegalovirus ie1 transactivates the alpha promoter-enhancer via an 18-base-pair repeat element. J Virol (1989) 4.25
Effector CD4+ and CD8+ T-cell mechanisms in the control of respiratory virus infections. Immunol Rev (1997) 3.88
NF-kappa B activation of the cytomegalovirus enhancer is mediated by a viral transactivator and by T cell stimulation. EMBO J (1989) 3.58
Site-specific inversion sequence of the herpes simplex virus genome: domain and structural features. Proc Natl Acad Sci U S A (1981) 3.45
Herpesvirus-dependent amplification and inversion of cell-associated viral thymidine kinase gene flanked by viral a sequences and linked to an origin of viral DNA replication. Proc Natl Acad Sci U S A (1982) 3.44
A DNA binding protein specific for an origin of replication of herpes simplex virus type 1. Proc Natl Acad Sci U S A (1986) 3.24
A cytomegalovirus-encoded mitochondria-localized inhibitor of apoptosis structurally unrelated to Bcl-2. Proc Natl Acad Sci U S A (1999) 3.22
A cis-acting element within the 5' leader of a cytomegalovirus beta transcript determines kinetic class. Cell (1986) 3.20
Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells. Proc Natl Acad Sci U S A (1998) 3.12
Insertion and deletion mutagenesis of the human cytomegalovirus genome. Proc Natl Acad Sci U S A (1987) 3.04
Human cytomegalovirus latent infection of granulocyte-macrophage progenitors. Proc Natl Acad Sci U S A (1994) 3.03
Transactivation of the cytomegalovirus ICP36 gene promoter requires the alpha gene product TRS1 in addition to IE1 and IE2. J Virol (1992) 2.95
Human cytomegalovirus latent gene expression in granulocyte-macrophage progenitors in culture and in seropositive individuals. Proc Natl Acad Sci U S A (1996) 2.87
Defective growth correlates with reduced accumulation of a viral DNA replication protein after low-multiplicity infection by a human cytomegalovirus ie1 mutant. J Virol (1998) 2.86
Regulation of cytomegalovirus late gene expression: gamma genes are controlled by posttranscriptional events. J Virol (1986) 2.84
A cytomegalovirus-encoded inhibitor of apoptosis that suppresses caspase-8 activation. Proc Natl Acad Sci U S A (2001) 2.80
Herpes simplex virus 1 helicase-primase: a complex of three herpes-encoded gene products. Proc Natl Acad Sci U S A (1989) 2.64
Human cytomegalovirus ie2 negatively regulates alpha gene expression via a short target sequence near the transcription start site. J Virol (1991) 2.61
Human cytomegalovirus infection inhibits G1/S transition. J Virol (1997) 2.61
Cytomegalovirus encodes a potent alpha chemokine. Proc Natl Acad Sci U S A (1999) 2.51
The alpha sequence of the cytomegalovirus genome functions as a cleavage/packaging signal for herpes simplex virus defective genomes. J Virol (1985) 2.46
Translational control of cytomegalovirus gene expression is mediated by upstream AUG codons. J Virol (1988) 2.35
Molecular evolution of herpesviruses: genomic and protein sequence comparisons. J Virol (1994) 2.34
Insertional mutagenesis of the murine cytomegalovirus genome: one prominent alpha gene (ie2) is dispensable for growth. Virology (1988) 2.17
DNA of human cytomegalovirus: size heterogeneity and defectiveness resulting from serial undiluted passage. J Virol (1979) 2.16
CD4(+) T cell-mediated control of a gamma-herpesvirus in B cell-deficient mice is mediated by IFN-gamma. Proc Natl Acad Sci U S A (1999) 2.14
Quantitative analysis of latent human cytomegalovirus. J Virol (1999) 2.11
Selectable insertion and deletion mutagenesis of the human cytomegalovirus genome using the Escherichia coli guanosine phosphoribosyl transferase (gpt) gene. J Gen Virol (1995) 2.10
Distinct and separate roles for herpesvirus-conserved UL97 kinase in cytomegalovirus DNA synthesis and encapsidation. Proc Natl Acad Sci U S A (2001) 2.10
Human cytomegalovirus origin of DNA replication (oriLyt) resides within a highly complex repetitive region. Proc Natl Acad Sci U S A (1992) 2.09
Herpes simplex virus latent RNA (LAT) is not required for latent infection in the mouse. Proc Natl Acad Sci U S A (1989) 2.05
Genes in the HindIII J fragment of the murine cytomegalovirus genome are dispensable for growth in cultured cells: insertion mutagenesis with a lacZ/gpt cassette. J Virol (1994) 1.98
Human cytomegalovirus uracil DNA glycosylase is required for the normal temporal regulation of both DNA synthesis and viral replication. J Virol (1996) 1.90
Pathogenesis of an infectious mononucleosis-like disease induced by a murine gamma-herpesvirus: role for a viral superantigen? J Exp Med (1997) 1.88
Regulation of cytomegalovirus late-gene expression: differential use of three start sites in the transcriptional activation of ICP36 gene expression. J Virol (1989) 1.83
Cytomegalovirus determinant of replication in salivary glands. J Virol (1992) 1.82
Infection of hematopoietic progenitor cells by human cytomegalovirus. Blood (1992) 1.76
A method to identify distinctive charge configurations in protein sequences, with application to human herpesvirus polypeptides. J Mol Biol (1989) 1.75
A DNA helicase induced by herpes simplex virus type 1. Nucleic Acids Res (1988) 1.70
Genomic organization and transcriptional regulation of the RANTES chemokine gene. J Immunol (1993) 1.70
Dramatic interstrain differences in the replication of human cytomegalovirus in SCID-hu mice. J Infect Dis (1995) 1.69
Formation of cytomegalovirus DNA replication compartments defined by localization of viral proteins and DNA synthesis. Virology (1997) 1.66
Analysis of the virus-specific and nonspecific B cell response to a persistent B-lymphotropic gammaherpesvirus. J Immunol (2000) 1.64
Cytokine production in the immune response to murine gammaherpesvirus 68. J Virol (1996) 1.61
Beta-galactosidase as a marker in the peripheral and neural tissues of the herpes simplex virus-infected mouse. Virology (1988) 1.60
Tuning into immunological dissonance: an experimental model for infectious mononucleosis. Curr Opin Immunol (1997) 1.56
A cytomegalovirus protein with properties of herpes simplex virus ICP8: partial purification of the polypeptide and map position of the gene. J Virol (1987) 1.55
Cytomegalovirus-encoded beta chemokine promotes monocyte-associated viremia in the host. Proc Natl Acad Sci U S A (1999) 1.53
Herpes simplex virus type 1 recombination: role of DNA replication and viral a sequences. J Virol (1992) 1.52
Precise localization of genes on large animal virus genomes: use of lambda gt11 and monoclonal antibodies to map the gene for a cytomegalovirus protein family. Proc Natl Acad Sci U S A (1985) 1.50
The cleavage recognition signal is contained within sequences surrounding an a-a junction in herpes simplex virus DNA. Virology (1988) 1.49
Immunological control of a murine gammaherpesvirus independent of CD8+ T cells. J Gen Virol (1999) 1.49
Murine cytomegalovirus IE2, an activator of gene expression, is dispensable for growth and latency in mice. Virology (1995) 1.44
Nucleotide sequence and structural features of a novel US-a junction present in a defective herpes simplex virus genome. J Virol (1985) 1.44
Modulation of natural killer cell cytotoxicity in human cytomegalovirus infection: the role of endogenous class I major histocompatibility complex and a viral class I homolog. J Exp Med (1998) 1.43
Requirement for CD40 ligand, CD4(+) T cells, and B cells in an infectious mononucleosis-like syndrome. J Virol (1999) 1.41
Kinetics of murine gammaherpesvirus 68 gene expression following infection of murine cells in culture and in mice. J Virol (2001) 1.39
Persistence of the cytomegalovirus genome in human cells. J Virol (1979) 1.39
Gamma interferon is not essential for recovery from acute infection with murine gammaherpesvirus 68. J Virol (1997) 1.38
Cytomegalovirus latency and latency-specific transcription in hematopoietic progenitors. Scand J Infect Dis Suppl (1995) 1.37
Murine cytomegalovirus CC chemokine homolog MCK-2 (m131-129) is a determinant of dissemination that increases inflammation at initial sites of infection. J Virol (2001) 1.37
A host cell protein binds to a highly conserved sequence element (pac-2) within the cytomegalovirus a sequence. J Virol (1989) 1.36
Peripheral blood CD14(+) cells from healthy subjects carry a circular conformation of latent cytomegalovirus genome. Blood (1999) 1.33
Structure and function of the murine cytomegalovirus sgg1 gene: a determinant of viral growth in salivary gland acinar cells. J Virol (1994) 1.32
Requirement for uracil-DNA glycosylase during the transition to late-phase cytomegalovirus DNA replication. J Virol (2001) 1.28
Structure and variability of the a sequence in the genome of human cytomegalovirus (Towne strain). J Gen Virol (1987) 1.27
Identification and preliminary use of recombinant lambda gt11 fusion proteins in human cytomegalovirus diagnosis. J Gen Virol (1989) 1.26
Membrane glycoproteins and antigens induced by human cytomegalovirus. J Gen Virol (1979) 1.23
Multiple infections by cytomegalovirus in patients with acquired immunodeficiency syndrome: documentation by Southern blot hybridization. J Infect Dis (1984) 1.22
Human cytomegalovirus late protein encoded by ie2: a trans-activator as well as a repressor of gene expression. J Gen Virol (1994) 1.21
Molecular genetic analysis of cytomegalovirus gene regulation in growth, persistence and latency. Curr Top Microbiol Immunol (1990) 1.19
Sequences within the herpesvirus-conserved pac1 and pac2 motifs are required for cleavage and packaging of the murine cytomegalovirus genome. J Virol (1998) 1.15
Apparent MHC-independent stimulation of CD8+ T cells in vivo during latent murine gammaherpesvirus infection. J Immunol (1999) 1.13
Isolation and characterization of an aminolevulinate-requiring Rhodobacter capsulatus mutant. J Bacteriol (1987) 1.11
Retinal degeneration is slowed in transgenic rats by AAV-mediated delivery of FGF-2. Invest Ophthalmol Vis Sci (2000) 1.10
Neutralizing epitopes on herpes simplex virus-1-expressed rotavirus VP7 are dependent on coexpression of other rotavirus proteins. Virology (1992) 1.09
Human cytomegalovirus latency-associated protein pORF94 is dispensable for productive and latent infection. J Virol (2000) 1.07
Cytomegalovirus viremia increases with progressive immune deficiency in patients infected with HTLV-III. AIDS Res (1986) 1.05
Fatal attraction: cytomegalovirus-encoded chemokine homologs. Curr Top Microbiol Immunol (2002) 1.02
Multicenter evaluation of PCR methods for detecting CMV DNA in blood donors. Transfusion (2001) 1.02
Recombinant AAV-mediated delivery of a tet-inducible reporter gene to the rat retina. Mol Ther (2001) 1.02
Pathogenesis of murine gammaherpesvirus-68 infection in interleukin-6-deficient mice. Virology (1998) 1.00
Humoral immune response to proteins of human cytomegalovirus latency-associated transcripts. Biol Blood Marrow Transplant (2000) 0.99
Immunological control of murine gammaherpesvirus infection is independent of perforin. J Gen Virol (1997) 0.97
Altering central nervous system physiology with a defective herpes simplex virus vector expressing the glucose transporter gene. Proc Natl Acad Sci U S A (1993) 0.96
Recombination in vitro between herpes simplex virus type 1 a sequences. Proc Natl Acad Sci U S A (1992) 0.93
Two animal models of retinal degeneration are rescued by recombinant adeno-associated virus-mediated production of FGF-5 and FGF-18. Mol Ther (2001) 0.92
Tetracycline-mediated regulation of gene expression within the human cytomegalovirus genome. Virology (1999) 0.92
Consequences of viral infections for lymphocyte compartmentalization and homeostasis. Semin Immunol (1997) 0.91
Cytomegalovirus enhances lysis of HIV-infected T lymphoblasts. Int J Cancer (1989) 0.91
Evidence for selective evolution in codon usage in conserved amino acid segments of human alphaherpesvirus proteins. J Mol Evol (1991) 0.87